| Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4–insufficient subjects C Schwab, A Gabrysch, P Olbrich, V Patiño, K Warnatz, D Wolff, ... Journal of Allergy and Clinical Immunology 142 (6), 1932-1946, 2018 | 438 | 2018 |
| IL-1β drives inflammatory responses to propionibacterium acnes in vitro and in vivo M Kistowska, S Gehrke, D Jankovic, K Kerl, A Fettelschoss, L Feldmeyer, ... Journal of Investigative Dermatology 134 (3), 677-685, 2014 | 277 | 2014 |
| AP1S3 mutations are associated with pustular psoriasis and impaired Toll-like receptor 3 trafficking N Setta-Kaffetzi, MA Simpson, AA Navarini, VM Patel, HC Lu, MH Allen, ... The American Journal of Human Genetics 94 (5), 790-797, 2014 | 221 | 2014 |
| Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score VK Tesch, H Abolhassani, B Shadur, J Zobel, Y Mareika, S Sharapova, ... Journal of Allergy and Clinical Immunology 145 (5), 1452-1463, 2020 | 144 | 2020 |
| Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations J Thalhammer, G Kindle, A Nieters, S Rusch, MRJ Seppänen, A Fischer, ... Journal of Allergy and Clinical Immunology 148 (5), 1332-1341. e5, 2021 | 119 | 2021 |
| Considerations on biologicals for patients with allergic disease in times of the COVID‐19 pandemic: an EAACI statement A Vultaggio, I Agache, CA Akdis, M Akdis, S Bavbek, A Bossios, ... Allergy 75 (11), 2764-2774, 2020 | 116 | 2020 |
| Canakinumab in adults with steroid‐refractory pyoderma gangrenosum AGA Kolios, JT Maul, B Meier, K Kerl, C Traidl‐Hoffmann, M Hertl, ... British Journal of Dermatology 173 (5), 1216-1223, 2015 | 112 | 2015 |
| Therapeutic options for CTLA-4 insufficiency D Egg, IC Rump, N Mitsuiki, J Rojas-Restrepo, ME Maccari, C Schwab, ... Journal of Allergy and Clinical Immunology 149 (2), 736-746, 2022 | 98 | 2022 |
| IL-4 receptor engagement in human neutrophils impairs their migration and extracellular trap formation D Impellizzieri, F Ridder, ME Raeber, C Egholm, J Woytschak, AGA Kolios, ... Journal of Allergy and Clinical Immunology 144 (1), 267-279. e4, 2019 | 91 | 2019 |
| Interleukin-2 and regulatory T cells in rheumatic diseases AGA Kolios, GC Tsokos, D Klatzmann Nature Reviews Rheumatology 17 (12), 749-766, 2021 | 85 | 2021 |
| Epidermal IL-15Rα acts as an endogenous antagonist of psoriasiform inflammation in mouse and man G Bouchaud, S Gehrke, C Krieg, A Kolios, J Hafner, AA Navarini, ... Journal of Experimental Medicine 210 (10), 2105-2117, 2013 | 74 | 2013 |
| Modulation of T cell responses by IL-2 and IL-2 complexes O Boyman, AGA Kolios, ME Raeber Clinical and experimental rheumatology 33 (4 Suppl 92), S54-S57, 2015 | 69 | 2015 |
| Swiss S1 guidelines on the systemic treatment of psoriasis vulgaris AGA Kolios, N Yawalkar, M Anliker, WH Boehncke, L Borradori, C Conrad, ... Dermatology 232 (4), 385-406, 2016 | 65 | 2016 |
| Biologicals in atopic disease in pregnancy: an EAACI position paper B Pfaller, J José Yepes‐Nuñez, I Agache, CA Akdis, M Alsalamah, ... Allergy 76 (1), 71-89, 2021 | 60 | 2021 |
| Low-dose excimer 308-nm laser for treatment of lichen planopilaris AA Navarini, AGA Kolios, BM Prinz-Vavricka, S Haug Archives of dermatology 147 (11), 1325-1326, 2011 | 58 | 2011 |
| Successful treatment of SAPHO syndrome with apremilast S Adamo, J Nilsson, A Krebs, U Steiner, A Cozzio, LE French, AGA Kolios British Journal of Dermatology 179 (4), 959-962, 2018 | 52 | 2018 |
| Identification of a novel PPAR β/δ/miR‐21‐3p axis in UV‐induced skin inflammation G Degueurce, I d'Errico, C Pich, M Ibberson, F Schütz, A Montagner, ... EMBO molecular medicine 8 (8), 919-936, 2016 | 50 | 2016 |
| Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: position paper of Ärzteverband Deutscher Allergologen (AeDA) A, Deutsche … L Klimek, O Pfaar, M Worm, T Eiwegger, J Hagemann, M Ollert, ... Allergologie select 4, 53, 2020 | 48 | 2020 |
| Topical treatment of psoriasis vulgaris: the Swiss treatment pathway JT Maul, F Anzengruber, C Conrad, A Cozzio, P Häusermann, A Jalili, ... Dermatology 237 (2), 166-178, 2021 | 43 | 2021 |
| Counter-regulation of T cell effector function by differentially activated p38 MS Alam, MM Gaida, Y Ogawa, AGA Kolios, F Lasitschka, JD Ashwell Journal of Experimental Medicine 211 (6), 1257-1270, 2014 | 43 | 2014 |
